Skip to main content

Table 1 Demographic and clinical characteristics, No. (%) of patients*

From: Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams

  

Previous Osteoporosis Diagnosis/Treatment

 
 

Overall Cohort (n = 342)

   
  

No

(n = 247)

Yes

(n = 95)

P

Demographic

    

Female

256 (74.9)

168 (68.0)

88 (92.6)

<0.001

Age in years; Mean (SD)‡

81.0 (10.2)

80.9 (10.6)

81.2 (9.0)

0.835

   Male

79.4 (10.3)

   

   Female

81.5 (10.1)

   

Previous Residence:

    

   Community

255 (74.6)

182 (73.7)

73 (76.8)

0.296

Admission Medications

    

Calcium and/or Vitamin D

53 (15.5)

24 (9.7)

29 (30.5)

<0.001

   Calcium

48 (14.0)

24 (9.7)

24 (25.3)

<0.001

   Vitamin D

31 (9.1)

9 (3.6)

22 (23.2)

<0.001

Any Anti-resorptive ≠

67 (19.6)

-

67 (70.5)

n/a

   Bisphosphonate ¶

60 (17.5)

-

60 (63.2)

n/a

   Raloxifene

3 (0.9)

-

3 (3.2)

n/a

   Calcitonin

0

-

0

n/a

   HRT

6 (1.8)

-

6 (6.3)

n/a

Comorbidities

    

Prior Fracture

112 (32.7)

67 (27.1)

45 (47.4)

<0.001

Cognitive impairment

117 (34.2)

88 (35.6)

29 (30.5)

0.373

Prior stroke

74 (21.6)

53 (21.5)

21(22.1)

0.896

Parkinson's disease

13 (3.8)

9 (3.6)

4 (4.2)

0.806

Frequent falls

54 (15.8)

38 (15.4)

16 (16.8)

0.741

In-Hospital

    

Acute care stay length in days; Mean (SD)

20.6 (19.4)

21.2 (20.7)

19.0 (15.5)

0.296

Total stay length in days§; Mean (SD)

31.2 (27.8)

31.4 (28.3)

30.6 (26.5)

0.795

Post-operative Care:

    

   Orthopedics Only

238 (69.6)

173 (70.0)

65 (68.4)

0.771

   Rehabilitation/Geriatrics

104 (30.4)

74 (30.0)

30 (31.6)

 

Radiographic Evidence £

90 (26.3)

60 (24.3)

30 (31.6)

0.170

Death prior to discharge

29 (8.5)

23 (9.3)

6 (6.3)

0.373

  1. SD = Standard Deviation NS = not significant; N/A = not applicable; OP = Osteoporosis
  2. *Unless stated otherwise. ‡No significant difference between men and women. ≠ Two patients were taking raloxifene and a bisphosphonate. ¶Alendronate, Etidronate, or Risedronate £Radiographic evidence of bone loss (see text). §Includes orthopedic service plus any transfers to rehabilitation or geriatrics services. †Comparison of 'no previous osteoporosis diagnosis/treatment' with 'previous osteoporosis diagnosis/treatment'.